Caprolactam Chemicals Share Price
45.80-2.14 (-4.46%)
+0.31% past 1 Year
Caprolactam Chemicals Ltd.has been involved in a phased manner in activities relating to setting up a project for manufacture of Glycol Ether Ethylene Oxide Condensate Emulsifier Vinyl Sulphone and Ethyl
Corporate filings & documents
Announcements
Annual Report for FY 2025-26
1 day agoAnnual Report for FY 2025-26
1 day agoNotice of Annual General Meeting on 28th September 2026
1 day agoNotice of Annual General Meeting on 28th September 2026
1 day agoRecommendation for Appointment of Statutory Auditor and Others Agenda items
3 days agoRecommendation for Appointment of Statutory Auditor and Others Agenda items
3 days agoNewspaper Advertisement of Unaudited Financial Result for the quarter ended on June 30th 2026
2 weeks agoNewspaper Advertisement of Unaudited Financial Result for the quarter ended on June 30th 2026
2 weeks agoOutcome of Board Meeting
3 weeks agoOutcome of Board Meeting
3 weeks agoCaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Prior Intimation of board meeting for unaudited financial results for the quarter ended June 30 2026
1 month agoCaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Prior Intimation of board meeting for unaudited financial results for the quarter ended June 30 2026
1 month agoCompliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
2 months agoCompliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
2 months agoClosure of Trading Window
2 months agoClosure of Trading Window
2 months agoNewspaper Advertisement of the Audited Financial Result for Quarter ended 31 March 2026
3 months agoNewspaper Advertisement of the Audited Financial Result for Quarter ended 31 March 2026
3 months agoOutcome of the Board Meeting held on Saturday 30 May 2026
3 months agoCaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Prior Intimation of Board Meeting to consider Audited Financial Results for quarter and financial year ended March 31 2026
4 months agoCaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Prior Intimation of Board Meeting to consider Audited Financial Results for quarter and financial year ended March 31 2026
4 months agoNon Applicability of Regulation 23(9) of SEBI (LODR) Regulations 2015
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Caprolactam Chemicals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110MH1988PLC049683</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>9.23</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Dolly Shah <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Siddharth Bhanushali <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 18/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Caprolactam Chemicals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110MH1988PLC049683</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>9.23</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Dolly Shah <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Siddharth Bhanushali <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 18/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoRegulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
5 months agoRegulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
5 months agoOutcome of postal ballot
5 months agoOutcome of postal ballot
5 months agoPOSTAL BALLOT SCRUTINIZERS REPORT
5 months agoPOSTAL BALLOT SCRUTINIZERS REPORT
5 months agoClosure of Trading Window
5 months agoPublic Notice by way of Advertisement in Newspapers for Postal Ballot
6 months agoPublic Notice by way of Advertisement in Newspapers for Postal Ballot
6 months agoIntimation of calendar of events for Postal Ballot
6 months agoIntimation of calendar of events for Postal Ballot
6 months agoIntimation of Notice of Postal Ballot
6 months agoNewspaper Advertisement of the Unaudited Financial Result for the Quarter ended on 31st December 2025
6 months agoResult For Quarter ended Dec 2025
6 months agoCaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Unaudited financial results for the Quarter ended 31st December 2025
7 months agoCompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
7 months agoClosure of Trading Window for the quarter ended December 31 2025
8 months agoSubmission of Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations 2015 Form C
9 months agoSubmission of Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations 2015 Form C
9 months agoDisclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011
9 months agoDisclosures under Regulations 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011
9 months agoDisclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011
9 months agoDisclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011
9 months agoDisclosures under Regulation 29 (2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011
9 months agoDisclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011
9 months agoDisclosure Under Regulation 29 (2) of SEBI (Substantial Acquisition of Shares And Takeovers) Regulations 2011
9 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
B 31, M I D C Taluka - Mahad Raigad Dist Maharashtra PIN: 402302 Tel No: 02145-233427 / 9869234017 / 9222076509 Fax No: 02145-233427 Email: [email protected] Internet: www.caprolactam.co.in
Registrars
Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg Gala No 9 Shiv Shakti, Industrial Estate,Sitaram Mill Comp. J R Boricha Marg, Lower Parel [E] PIN: Tel No: +91 22 4134 3255/ +91 22 4134 3256 Fax No: NULL Email: [email protected] Internet: www.purvashare.com
Management
Viren Jaysukhlal Jasani, Non Executive Independent Director
Kamlesh Damji Joisher, Non Executive Independent Director
Poonam Bhavin Bhanushali, Non Executive Independent Director
Dolly Dipesh Shah, Company Secretary & Compliance Officer
Zaver Shankarlal Bhanushali, Chairman & Managing Director
Zaver Shankarlal Bhanushali, Chairman & Managing Director
Siddharth Shankarlal Bhanushali, Whole Time Director & Chief Financial Officer
Details
BSE 507486
NSE NULL
ISIN INE470N01010